Human biomonitoring assessment values: approaches and data requirements
Jürgen Angerer1, Lesa L Aylward, Sean M Hays
1Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr-University Bochum, Germany.
Human biomonitoring (HBM) assessment values help evaluate chemical exposures. New methods translate external dose guidance into biomonitoring levels, expanding HBM data interpretation for more chemicals and populations.
Area of Science:
- Environmental Health Sciences
- Toxicology
- Biomonitoring
Background:
- Human biomonitoring (HBM) data is crucial for assessing chemical exposures.
- Health risk assessment requires HBM assessment values, but data is limited for many chemicals.
- Existing HBM assessment values derived from human exposure-response data are scarce.
Purpose of the Study:
- To review and demonstrate approaches for deriving HBM assessment values.
- To expand the range of chemicals with available HBM assessment values.
- To provide tools for evaluating HBM data across diverse chemicals and populations.
Main Methods:
- Translating external dose-based guidance values (e.g., tolerable daily intakes) into equivalent biomonitoring levels.
- Reviewing the development of HBM values by the German HBM Commission.
- Examining Biomonitoring Equivalents developed by Summit Toxicology.
Main Results:
- Conceptually similar assessment values have been developed by different organizations.
- Approaches exist to broaden the derivation of HBM assessment values for more chemicals.
- HBM assessment values have been published for over 80 chemicals.
Conclusions:
- The reviewed methods and examples facilitate the derivation of HBM assessment values.
- These derived values enhance the evaluation of HBM data.
- Expanded HBM assessment values support broader chemical and population risk assessment.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Assessment of blood pressure in brachial artery(two-step method)
Model Approaches for Pharmacokinetic Data: Physiological Models


